1. Home
  2. PTHL vs LCFY Comparison

PTHL vs LCFY Comparison

Compare PTHL & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • LCFY
  • Stock Information
  • Founded
  • PTHL 1998
  • LCFY 2009
  • Country
  • PTHL China
  • LCFY Australia
  • Employees
  • PTHL N/A
  • LCFY N/A
  • Industry
  • PTHL
  • LCFY
  • Sector
  • PTHL
  • LCFY
  • Exchange
  • PTHL Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • PTHL 8.8M
  • LCFY 9.2M
  • IPO Year
  • PTHL 2024
  • LCFY 2022
  • Fundamental
  • Price
  • PTHL $0.60
  • LCFY $3.61
  • Analyst Decision
  • PTHL
  • LCFY
  • Analyst Count
  • PTHL 0
  • LCFY 0
  • Target Price
  • PTHL N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • PTHL 119.0K
  • LCFY 19.6K
  • Earning Date
  • PTHL 01-01-0001
  • LCFY 11-12-2025
  • Dividend Yield
  • PTHL N/A
  • LCFY N/A
  • EPS Growth
  • PTHL N/A
  • LCFY N/A
  • EPS
  • PTHL N/A
  • LCFY N/A
  • Revenue
  • PTHL $448,196.00
  • LCFY $2,099,713.00
  • Revenue This Year
  • PTHL N/A
  • LCFY N/A
  • Revenue Next Year
  • PTHL N/A
  • LCFY N/A
  • P/E Ratio
  • PTHL N/A
  • LCFY N/A
  • Revenue Growth
  • PTHL N/A
  • LCFY N/A
  • 52 Week Low
  • PTHL $0.47
  • LCFY $2.51
  • 52 Week High
  • PTHL $32.00
  • LCFY $13.98
  • Technical
  • Relative Strength Index (RSI)
  • PTHL 44.14
  • LCFY 38.56
  • Support Level
  • PTHL $0.55
  • LCFY $3.15
  • Resistance Level
  • PTHL $0.62
  • LCFY $3.78
  • Average True Range (ATR)
  • PTHL 0.05
  • LCFY 0.27
  • MACD
  • PTHL 0.02
  • LCFY 0.05
  • Stochastic Oscillator
  • PTHL 58.80
  • LCFY 50.79

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: